News
GE HealthCare’s commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on ...
FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.
MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano MedPromising tumor ...
(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to a session on non-beta emitter PSMA radioligand therapy. Dr.
In the US, patients diagnosed with noninfectious uveitis (NIU) are higher in number than infectious uveitis (IU). In 2022, ...
Pulsar UK has signed an agreement with Thales Alenia Space (TAS) for the Pulsar’s 5kW MOONRANGER Hall-effect thrusters, which ...
Hazleton, part of Jefferson Health, we continuously pursue ways to better serve our community. Those aren’t empty words.
5don MSN
For the first time since the global outbreak of Covid-19, researchers claim to have pierced North Korea’s ironclad information blockade to reveal how some ordinary citizens endured the pandemic. While ...
PORTLAND, IN, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- According to the report, the global radiopharmaceuticals industry generated $7.9 billion in 2023, and is anticipated to generate $21.8 ...
Two newly developed PET imaging agents have been proven effective in identifying the histamine H3 receptor (H3R) that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results